[email protected]
DRUGSCAN: A legacy of impeccable science and service
Since our founding in 1985 as an accredited toxicology laboratory, we have been unwavering in our mission to provide clients with advanced technology, accurate results and superior customer service nationwide. We are passionate about what we do because we understand the critical impact this will have on patient care and treatment.
For over 30 years, DRUGSCAN has had an ongoing commitment to provide premier drug monitoring solutions. Our deep scientific expertise, proprietary reporting and marketplace insight has culminated in our leadership position in the following areas:
[email protected]
DRUGSCAN's distinguished leadership team is highly respected throughout the laboratory industry. Its members are affiliated with the most prestigious organizations in the industry. Great science, service, and quality are the reasons why the DRUGSCAN team has earned a reputation for excellence.
[email protected]
Employees working at DRUGSCAN make a difference in the communities they serve
Our employees are passionate about everything they do. We are extremely proud to have the most dedicated, committed and talented colleagues in the entire laboratory industry.
Delivering outstanding customer service and accurate results is what we’re all about because we are humbled by the trust clients place in us and we do not take that trust lightly. We strive to anticipate our clients’ needs and exceed their expectations every day.
with DRUGSCAN.
What makes DRUGSCAN special?
[email protected]
At DRUGSCAN, we are humbled by the trust clients place in us and we do not take that trust lightly.
For over 30 years, we have been unwavering in our mission to provide clients with advanced technology, accurate results and superior customer service nationwide. We are passionate about what we do because we understand the critical impact this will have on patient care and treatment.
At DRUGSCAN, we adhere to a strict Compliance Policy developed to ensure DRUGSCAN complies with all relevant laws, legal, ethical and regulatory obligations, and upholds the highest standards in the industry.
DRUGSCAN works to ensure that every aspect of our business fully complies with the relevant requirements of the STARK Laws, the Anti-Kickback Statute, and the False Claims Act.
[email protected]
DRUGSCAN has an ongoing commitment to provide the highest quality drug and alcohol monitoring solutions through Great Chemistry
We are one of a few nationally CAP accredited and SAMHSA certified toxicology laboratories
DRUGSCAN is also certified in multiple states as well as CLIA
Proficiency testing provides information that ensures we have the right equipment, accurate and robust methods, and properly trained staff
This webinar features interviews with recreational and dependent prescription opioid abusers offering a rare look into the manipulation techniques abusers use to prepare opioid tablets for routes of administration that provide a more powerful euphoria, such as intravenous or intranasal. The webinar also discusses the laboratory experiments DRUGSCAN scientists conduct to evaluate the properties of abuse-deterrent formulations that are designed to resist these manipulation techniques
HORSHAM, Pa., June 19, 2017 /PRNewswire/ -- Researchers from DRUGSCAN® and INC Research® announced today that they will host a live, complimentary webinar titled, "Untangling methods to tamper with opioid formulations: Perspectives from the benchtop to the real world" on Wednesday June 28, 2017 from 12:00 PM to 1:00 PM EDT.
Eric Kinzler and Chris Altomare of DRUGSCAN discuss designing in vitro mastication studies for abuse-deterrent formulations.
DRUGSCAN® to Present Scientific Data at the 2016 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition
DRUGSCAN® to Present Scientific Data at the PAINWeek 2016 Conference
Horsham, PA (April 27, 2016) – Experts from DrugScan®, PinneyAssociatessm, and INC Research® announced today that they will host a live, complimentary webinar titled, "Understanding the FDA's Abuse-Deterrent Guidance for Innovator and Generic Opioids - The Evolving Pathway for Development and Labeling", on Wednesday May 25, 2016 from 12:00 PM to 1:00 PM EDT.
[email protected]
DRUGSCAN has an ongoing commitment to provide the highest quality drug and alcohol monitoring solutions through Great Chemistry
We are one of a few nationally CAP accredited and SAMHSA certified toxicology laboratories
DRUGSCAN is also certified in multiple states as well as CLIA
Proficiency testing provides information that ensures we have the right equipment, accurate and robust methods, and properly trained staff
This webinar features interviews with recreational and dependent prescription opioid abusers offering a rare look into the manipulation techniques abusers use to prepare opioid tablets for routes of administration that provide a more powerful euphoria, such as intravenous or intranasal. The webinar also discusses the laboratory experiments DRUGSCAN scientists conduct to evaluate the properties of abuse-deterrent formulations that are designed to resist these manipulation techniques
HORSHAM, Pa., June 19, 2017 /PRNewswire/ -- Researchers from DRUGSCAN® and INC Research® announced today that they will host a live, complimentary webinar titled, "Untangling methods to tamper with opioid formulations: Perspectives from the benchtop to the real world" on Wednesday June 28, 2017 from 12:00 PM to 1:00 PM EDT.
Eric Kinzler and Chris Altomare of DRUGSCAN discuss designing in vitro mastication studies for abuse-deterrent formulations.
DRUGSCAN® to Present Scientific Data at the 2016 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition
DRUGSCAN® to Present Scientific Data at the PAINWeek 2016 Conference
Horsham, PA (April 27, 2016) – Experts from DrugScan®, PinneyAssociatessm, and INC Research® announced today that they will host a live, complimentary webinar titled, "Understanding the FDA's Abuse-Deterrent Guidance for Innovator and Generic Opioids - The Evolving Pathway for Development and Labeling", on Wednesday May 25, 2016 from 12:00 PM to 1:00 PM EDT.